ANGPTL7 and glaucoma: This study establishes strong genetic evidence for the involvement of ANGPTL7 in glaucoma risk in which a powerful allelic series, including multiple low-frequency missense substitutions and a single premature stop-gain substitution, is conclusively associated with reduced disease risk and endophenotype-lowering effects.